Full Coverage

Avastin(R) Continues to Demonstrate Long Term Survival for Patients With Metastatic Colorectal...

                   
finanznachrichten.de
Sep 12, 2008
        
Story Timeline:  83 days

Basel, Switzerland (ots/PRNewswire) - - Avastin Shows Unprecedented Patient Benefits Regardless of K-Ras Status, Age and Chemotherapy Choice Avastin's (bevacizumab) essential role in the treatment of patients with metastatic colorectal cancer (mCRC), the world's second most common cancer, was strengthened at the 33rd European Society of Medical Oncology (ESMO) meeting with a compelling data set including: - the... [read full story]                    

Add Comment
Latest article on this story:

Avastin(R) Continues to Demonstrate Long Term Survival

 antara.co.id Sep 12, 2008
First article on this story:

Avastin (bevacizumab) shows patient benefits regardless of K-Ras status, age and chemotherapy choice

 pharmiweb.co.uk Sep 12, 2008
Selected publications with coverage of this story:
antara.co.id pharmiweb.co.uk finanznachrichten.de
RELATED
Found 1 documents:
                   

Avastin(R) Continues to Demonstrate Long Term Survival

antara.co.id
Sep 12, 2008
        

for Patients With Metastatic Colorectal Cancer BASEL, Sept 12 (ANTARA/PRNewswire-AsiaNet) - - survival reported from First BEAT (1) The long term benefits of Avastin use in combination with chemotherapy were confirmed...